Optimizing Efficacy: Titration allows your healthcare provider to find the lowest effective dose for you, which helps maximize benefits while minimizing potential risks
We liaise directly with insurance companies to obtain necessary approvals, making your transition to semaglutide treatment seamless
Rarely, people may develop hives or immune-related skin conditions that require stopping the drug
The FDA's Adverse Event Reporting System (FAERS) contains no specific signals suggesting dangerous combinations of GLP-1 agonists with common oral antibiotics
El K, Douros JD, Willard FS et al (2023) The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets
The GI trial data confirms pharmacological activity in humans and an acceptable short-term safety profile in surgical patients it does not confirm GH stimulation efficacy in healthy adults, body composition effects, or recovery acceleration in athletic contexts